Article info
PDFClinical science
Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma
- Correspondence to Dr Santosh G Honavar, National Retinoblastoma Foundation, Ocular Oncology Service, Centre for Sight, Hyderabad, 500034, India; santosh.honavar{at}gmail.com
Citation
Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma
Publication history
- Received April 25, 2017
- Revised July 22, 2017
- Accepted July 25, 2017
- First published August 26, 2017.
Online issue publication
March 23, 2018
Article Versions
- Previous version (23 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.